Shopping Cart
- Remove All
- Your shopping cart is currently empty
SB 706504 is an effective p38 MAPK inhibitor that suppresses inflammatory gene expression in macrophages and inhibits TNFα production in LPS-stimulated chronic obstructive pulmonary disease (COPD).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $93 | In Stock | |
5 mg | $228 | In Stock | |
10 mg | $342 | In Stock | |
25 mg | $572 | In Stock | |
50 mg | $813 | In Stock |
Description | SB 706504 is an effective p38 MAPK inhibitor that suppresses inflammatory gene expression in macrophages and inhibits TNFα production in LPS-stimulated chronic obstructive pulmonary disease (COPD). |
In vitro | Methods: Alveolar macrophages (AMs) were treated with SB 706504 (3 μM, 0.5 hours), and the TNFα protein levels in the cell culture supernatant were analyzed using enzyme-linked immunoadsorption assay (ELISA). Results: SB 706504 significantly reduced the protein levels of TNFα.[1] |
Synonyms | BLZ-945 hydrochloride, BLZ945 hydrochloride |
Molecular Weight | 492.46 |
Formula | C24H19F3N8O |
Cas No. | 911110-38-8 |
Smiles | O=C1N(C=2C(=C(N=C(NCCNC(NC#N)=N)N2)C3=C(C)C=C(F)C=C3)C=C1)C4=C(F)C=CC=C4F |
Relative Density. | no data available |
Color | White |
Appearance | Solid |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Solubility Information | DMSO: <49.25 mg/mL, Sonication is recommended. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.